Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer.
Katsube T, Ogawa K, Ichikawa W, Fujii M, Tokunaga A, Takagi Y, Kochi M, Hayashi K, Kubota T, Aiba K, Arai K, Terashima M, Kitajima M.
Katsube T, et al. Among authors: ichikawa w.
Anticancer Drugs. 2007 Jun;18(5):605-10. doi: 10.1097/CAD.0b013e3280262460.
Anticancer Drugs. 2007.
PMID: 17414630
Clinical Trial.